NRSNW
NeuroSense Therapeutics Ltd.
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 6-K | 8/13/2026 | View on SEC |
| 6-K | 8/6/2026 | View on SEC |
| EFFECT | 7/31/2026 | View on SEC |
| 6-K | 7/31/2026 | View on SEC |
| 6-K | 7/31/2026 | View on SEC |
| F-3/A | 7/30/2026 | View on SEC |
| 6-K | 7/22/2026 | View on SEC |
| 6-K | 6/29/2026 | View on SEC |
| 6-K | 6/25/2026 | View on SEC |
| 4 | 6/17/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NRSNW |
| Company Name | NeuroSense Therapeutics Ltd. |
| CIK | 1875091 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | L3 |
| Phone | 972-9-9531142 |